Related Experiment Video
Updated: Apr 23, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
Detection of SQSTM1/P392L post-zygotic mutations in Paget's disease of bone
Sabrina Guay-Bélanger1, Sylvain Picard, Edith Gagnon
1CHU de Québec Research Centre, Rhumatologie-R4774, CHU de Québec, 2705 boulevard Laurier, Québec, QC, G1V 4G2, Canada.
Abstract:
Paget's disease of bone (PDB) is transmitted, in one-third of cases, in an autosomal dominant mode of inheritance with incomplete penetrance. The SQSTM1/P392L germinal mutation is the most common mutation associated with PDB. Given the focal nature of PDB, one team of investigators showed that SQSTM1/P392L somatic mutations could occur in pagetic bone lesions in the absence of germinal mutations detectable in the peripheral blood. The objectives of this study were to develop a reliable method to detect SQSTM1/P392L post-zygotic mutations, by optimizing a polymerase chain reaction (PCR)-clamping method reported to be effective in detecting post-zygotic mutations in peripheral blood from patients with fibrous dysplasia; and to evaluate the frequency of this post-zygotic mutation in PDB patients. We used a locked nucleic acid (LNA) specifically designed for the SQSTM1/P392L mutation, which blocks the wild-type allele amplification during the PCR. DNA from 376 pagetic patients and 297 controls, all without any SQSTM1/P392L germinal mutation, was analyzed. We found that 4.8 % of PDB patients and 1.4 % of controls were carriers of this post-zygotic mutation [p = 0.013, OR 3.68 (1.23; 11.00)]. PDB patient carriers of a post-zygotic mutation had a lower number of affected bones and Renier's index than patients carrying a germinal mutation, suggesting a lower disease extension. We also demonstrated that this post-zygotic mutation was restricted to the monocytic lineage. These results confirmed that LNA PCR clamping is effective for the detection of SQSTM1/P392L post-zygotic mutations, which may occur in patients with PDB.
Insights
A new method detects post-zygotic SQSTM1/P392L mutations in Paget's disease of bone (PDB). This mutation was found in 4.8% of PDB patients without germline mutations, suggesting a lower disease extension.
Area of Science:
- Genetics
- Bone Biology
- Molecular Biology
Background:
- Paget's disease of bone (PDB) often follows autosomal dominant inheritance with incomplete penetrance.
- The SQSTM1/P392L mutation is frequently associated with PDB.
- Somatic SQSTM1/P392L mutations in bone lesions may occur independently of germline mutations.
Purpose of the Study:
- To develop a reliable method for detecting post-zygotic SQSTM1/P392L mutations.
- To optimize a polymerase chain reaction (PCR)-clamping method using locked nucleic acid (LNA) for mutation detection.
- To determine the frequency of post-zygotic SQSTM1/P392L mutations in PDB patients.
Main Methods:
- A locked nucleic acid (LNA) PCR-clamping technique was employed to specifically amplify the SQSTM1/P392L mutation.
- DNA from 376 PDB patients and 297 controls, confirmed negative for germline mutations, was analyzed.
- The amplification of the wild-type allele was inhibited using the LNA probe during PCR.
Main Results:
- The LNA PCR clamping method effectively detected post-zygotic SQSTM1/P392L mutations.
- Post-zygotic SQSTM1/P392L mutations were identified in 4.8% of PDB patients and 1.4% of controls (p=0.013).
- PDB patients with post-zygotic mutations exhibited less extensive disease compared to those with germline mutations.
Conclusions:
- Post-zygotic SQSTM1/P392L mutations are present in a subset of PDB patients.
- The LNA PCR clamping method is a viable tool for detecting these somatic mutations.
- The presence of post-zygotic mutations may correlate with a milder form of Paget's disease of bone.

